Study guide
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation
Key Takeaways Explain This Topic AI
Phase II cardiac rehabilitation exercise frequency mandates a minimum of 3 days per week of supervised aerobic training, progressing toward 5 or more days per week of combined supervised and home exercise.
Aerobic intensity is prescribed across 40% to 80% of Heart Rate Reserve (HRR) or Oxygen Uptake Reserve (VO2R), corresponding to moderate (40% to 59%) and vigorous (60% to 80%) training domains.
The Karvonen formula calculates Target Heart Rate as [(HRmax - HRrest) x %intensity] + HRrest, while VO2 Reserve incorporates standardized resting metabolic rate: Target VO2 = [(VO2max - VO2rest) x %intensity] + VO2rest, where VO2rest equals 3.5 mL/kg/min (1 MET).
In patients receiving beta-adrenergic antagonist therapy, chronotropic blunting renders age-predicted heart rate equations invalid, necessitating the Borg 6-20 RPE scale (target 12-16) or Omni 0-10 scale (target 4-7) for intensity titration.
The mandatory ischemic threshold rule dictates that in patients with exercise-induced myocardial ischemia, the upper target heart rate must be capped at least 10 bpm below the heart rate at which angina or >= 1.0 mm ST-segment depression was elicited on testing.
Last updated: September 2026
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation
Aerobic exercise training serves as the central therapeutic modality in secondary cardiovascular prevention. Clinical exercise physiologists and cardiac rehabilitation nurses translate diagnostic data into individualized exercise prescriptions using the FITT-VP principle ( F requency, I ntensity, T ime, T ype, V olume, and P rogression). A structured exercise prescription enhances peak oxygen consumption ( VO 2 peak \text{VO}_{2\text{peak}} VO 2 peak ), improves endothelial function, attenuates myocardial ischemia, and reduces cardiovascular mortality by 20% to 30%.
- The FITT-VP Framework in Cardiovascular Disease
- 1. Frequency
Supervised Phase II Clinical Rehabilitation : A minimum of 3 days per week of structured, supervised exercise is required to achieve cardiorespiratory conditioning and facilitate continuous risk stratification.
Long-Term Target (Supervised + Independent) : Progressing toward 5 or more days per week of aerobic physical activity. Accumulated non-supervised physical activity on non-rehabilitation days reinforces lifestyle behavioral adoption and accelerates caloric expenditure.
2. Intensity
Aerobic intensity is calibrated across established physiologic boundaries based on baseline functional capacity:
Light Intensity (30% to 39% HRR / VO 2 R \text{VO}_{2}\text{R} VO 2 R , Borg RPE 9–11) : Indicated during initial sessions for severely deconditioned individuals, patients recovering from prolonged hospitalization, or those with symptomatic heart failure (NYHA Class III).
Moderate Intensity (40% to 59% HRR / VO 2 R \text{VO}_{2}\text{R} VO 2 R , Borg RPE 12–13 "somewhat hard") : The foundational starting range for the majority of stable cardiovascular patients entering Phase II rehabilitation.
Vigorous Intensity (60% to 80% HRR / VO 2 R \text{VO}_{2}\text{R} VO 2 R , Borg RPE 14–16 "hard") : Reserved for lower-risk, clinically stable patients after 4 to 6 weeks of documented exercise tolerance to maximize cardiorespiratory fitness.
3. Time (Duration)
Continuous Aerobic Conditioning : 20 to 60 minutes per session, excluding dedicated 5- to 10-minute warm-up and cool-down periods.
Deconditioned / Low-Capacity Patients ( < 5 METs <5\text{ METs} < 5 METs ) : Initiate training with intermittent interval bouts of 5 to 10 minutes of low-to-moderate intensity exercise alternating with seated rest, gradually accumulating 20 to 30 minutes of total daily exercise before progressing to continuous conditioning.
4. Type (Modality)
Dynamic, rhythmic activities recruiting large skeletal muscle masses: motorized treadmill walking, upright and recumbent cycle ergometry, recumbent stepping (e.g., NuStep), upper-body arm ergometry, elliptical cross-training, and rowing ergometry. Rotating across diverse modalities engages upper and lower extremities, minimizes localized musculoskeletal fatigue, and accommodates orthopedic restrictions.
5. Volume (Total Energy Expenditure)
Weekly volume targets an energy expenditure of ≥ 500 – 1 , 000 MET-minutes/week \ge 500\text{--}1,000\text{ MET-minutes/week} ≥ 500 – 1 , 000 MET-minutes/week , corresponding approximately to 1 , 000 – 2 , 000 kcal/week 1,000\text{--}2,000\text{ kcal/week} 1 , 000 – 2 , 000 kcal/week or 150 minutes per week of moderate-intensity physical activity. This dose-response threshold is associated with significant reductions in major adverse cardiovascular events (MACE) and progression of coronary atherosclerosis.
6. Progression
Gradual progressive overload applied systematically: increase duration first (expanding total continuous minutes) before increasing workload, speed, or treadmill grade.
- FITT-VP Component Initial Phase II Recommendation Advanced / Maintenance Target
- Frequency 3 days/week supervised ≥ 5 \ge 5 ≥ 5 days/week (combined supervised + home)
Intensity 40%–50% HRR / VO 2 R \text{VO}_{2}\text{R} VO 2 R (RPE 11–13) 60%–80% HRR / VO 2 R \text{VO}_{2}\text{R} VO 2 R (RPE 14–16)
Time (Duration) 15–30 min continuous or accumulated bouts 30–60 min continuous dynamic conditioning
Type (Mode) Large-muscle rhythmic (treadmill, cycle, stepper) Multi-modality cross-training and outdoor walking
Volume ≥ 500 MET-min/week \ge 500\text{ MET-min/week} ≥ 500 MET-min/week 1 , 000 – 2 , 000 kcal/week 1,000\text{--}2,000\text{ kcal/week} 1 , 000 – 2 , 000 kcal/week ( ≥ 1 , 000 MET-min/wk \ge 1,000\text{ MET-min/wk} ≥ 1 , 000 MET-min/wk )
- Progression Duration increases of 1–5 min every 1–2 sessions Workload/intensity increases of 5%–10% increments
- Exercise Intensity Calculation Methodologies
- 1. Heart Rate Reserve (Karvonen Method)
The Heart Rate Reserve (HRR) equation accounts for individual differences in resting heart rate and establishes a direct linear relationship with relative metabolic strain: Target HR (THR) = [ ( HR max − HR rest ) × % intensity ] + HR rest \text{Target HR (THR)} = [(\text{HR}_{\max} - \text{HR}_{\text{rest}}) \times \%\text{intensity}] + \text{HR}_{\text{rest}} Target HR (THR) = [( HR m a x − HR rest ) × % intensity ] + HR rest
Step-by-Step Calculation :
A 62-year-old male post-CABG achieves a peak heart rate of 150 bpm 150\text{ bpm} 150 bpm on a symptom-limited graded exercise test (GXT). His resting heart rate is 60 bpm 60\text{ bpm} 60 bpm . The clinician prescribes exercise at 50% to 70% HRR :
HRR = 150 − 60 = 90 bpm \text{HRR} = 150 - 60 = 90\text{ bpm} HRR = 150 − 60 = 90 bpm
Lower Target HR (50%) = ( 90 × 0.50 ) + 60 = 45 + 60 = 105 bpm \text{Lower Target HR (50\%)} = (90 \times 0.50) + 60 = 45 + 60 = 105\text{ bpm} Lower Target HR (50%) = ( 90 × 0.50 ) + 60 = 45 + 60 = 105 bpm
Upper Target HR (70%) = ( 90 × 0.70 ) + 60 = 63 + 60 = 123 bpm \text{Upper Target HR (70\%)} = (90 \times 0.70) + 60 = 63 + 60 = 123\text{ bpm} Upper Target HR (70%) = ( 90 × 0.70 ) + 60 = 63 + 60 = 123 bpm
- Prescribed Target Heart Rate Zone : 105 to 123 bpm 105\text{ to } 123\text{ bpm} 105 to 123 bpm
- 2. Oxygen Uptake Reserve ( VO 2 R \text{VO}_{2}\text{R} VO 2 R )
The Oxygen Uptake Reserve method parallels HRR by accounting for baseline resting metabolic expenditure, standardized at 3.5 mL/kg/min 3.5\text{ mL/kg/min} 3.5 mL/kg/min (equivalent to 1 Metabolic Equivalent, or 1 MET): Target VO 2 = [ ( VO 2 peak − VO 2 rest ) × % intensity ] + VO 2 rest ( where VO 2 rest = 3.5 mL/kg/min ) \text{Target } \text{VO}_{2} = [(\text{VO}_{2\text{peak}} - \text{VO}_{2\text{rest}}) \times \%\text{intensity}] + \text{VO}_{2\text{rest}} \quad (\text{where } \text{VO}_{2\text{rest}} = 3.5\text{ mL/kg/min}) Target VO 2 = [( VO 2 peak − VO 2 rest ) × % intensity ] + VO 2 rest ( where VO 2 rest = 3.5 mL/kg/min )
Unlike straight percentages of peak VO 2 \text{VO}_{2} VO 2 (which underestimate relative intensity at lower workloads), percentage of VO 2 R \text{VO}_{2}\text{R} VO 2 R is physiologically equivalent to percentage of HRR: % HRR ≈ % VO 2 R \%\text{HRR} \approx \%\text{VO}_{2}\text{R} % HRR ≈ % VO 2 R
Calculation Example :
A patient with ischemic cardiomyopathy achieves a VO 2 peak \text{VO}_{2\text{peak}} VO 2 peak of 21.0 mL/kg/min 21.0\text{ mL/kg/min} 21.0 mL/kg/min (6.0 METs). Prescribed intensity is 40% to 60% VO 2 R \text{VO}_{2}\text{R} VO 2 R :
VO 2 R = 21.0 − 3.5 = 17.5 mL/kg/min \text{VO}_{2}\text{R} = 21.0 - 3.5 = 17.5\text{ mL/kg/min} VO 2 R = 21.0 − 3.5 = 17.5 mL/kg/min
Lower Target VO 2 ( 40 % ) = ( 17.5 × 0.40 ) + 3.5 = 7.0 + 3.5 = 10.5 mL/kg/min ( 3.0 METs ) \text{Lower Target } \text{VO}_{2} (40\%) = (17.5 \times 0.40) + 3.5 = 7.0 + 3.5 = 10.5\text{ mL/kg/min} \quad (3.0\text{ METs}) Lower Target VO 2 ( 40% ) = ( 17.5 × 0.40 ) + 3.5 = 7.0 + 3.5 = 10.5 mL/kg/min ( 3.0 METs )
Upper Target VO 2 ( 60 % ) = ( 17.5 × 0.60 ) + 3.5 = 10.5 + 3.5 = 14.0 mL/kg/min ( 4.0 METs ) \text{Upper Target } \text{VO}_{2} (60\%) = (17.5 \times 0.60) + 3.5 = 10.5 + 3.5 = 14.0\text{ mL/kg/min} \quad (4.0\text{ METs}) Upper Target VO 2 ( 60% ) = ( 17.5 × 0.60 ) + 3.5 = 10.5 + 3.5 = 14.0 mL/kg/min ( 4.0 METs )
3. Rating of Perceived Exertion (RPE): Borg & Omni Scales
Subjective ratings of perceived exertion are vital clinical tools in cardiovascular rehabilitation:
Borg 6–20 Scale : Target range of 12 to 16 ("somewhat hard" to "hard").
Omni 0–10 Scale : Target range of 4 to 7 ("somewhat easy" to "hard").
Indispensability in Beta-Blockade
Beta-adrenergic antagonists (e.g., metoprolol, carvedilol) competitively block beta-1 receptors in the sinoatrial node, producing profound chronotropic blunting : resting heart rate decreases by 10 to 15 bpm and peak exertional heart rate is suppressed by 20 to 30 bpm. Consequently, age-predicted maximal heart rate equations (e.g., 220 − age 220 - \text{age} 220 − age ) underestimate or distort exercise capacity and must never be utilized. In patients on beta-blockers, without a recent GXT on current medications, or with chronotropic incompetence, RPE serves as the primary intensity guide , accurately tracking blood lactate thresholds and ventilatory strain.
4. The Talk Test & Ventilatory Threshold
The Talk Test serves as an accessible, non-invasive surrogate for the first ventilatory threshold ( VT 1 \text{VT}_1 VT 1 ) . When an exercising patient can speak comfortably in full sentences without gasping, exertion remains below VT 1 \text{VT}_1 VT 1 (moderate intensity). Once speech becomes broken and pauses are required between words, exercise has crossed VT 1 \text{VT}_1 VT 1 toward the respiratory compensation threshold ( VT 2 \text{VT}_2 VT 2 ), marking vigorous anaerobic metabolism.
The Mandatory Ischemic Threshold Rule
Myocardial oxygen demand is determined by the rate-pressure product ( RPP = HR × SBP \text{RPP} = \text{HR} \times \text{SBP} RPP = HR × SBP ). In patients with coronary artery disease and incomplete revascularization or residual stenoses, myocardial ischemia occurs at a reproducible hemodynamic threshold.
Important
Ischemic Threshold Prescription Mandate :
If a patient demonstrates exercise-induced myocardial ischemia—manifested by exertional angina, ≥ 1.0 mm \ge 1.0\text{ mm} ≥ 1.0 mm horizontal or downsloping ST-segment depression, or a reversible perfusion defect on stress imaging—the upper limit of the target heart rate must be capped at least 10 bpm below the heart rate at which ischemic signs or symptoms occurred .
Upper Target Heart Rate ≤ Ischemic Threshold Heart Rate − 10 bpm \text{Upper Target Heart Rate} \le \text{Ischemic Threshold Heart Rate} - 10\text{ bpm} Upper Target Heart Rate ≤ Ischemic Threshold Heart Rate − 10 bpm
Clinical Application Scenario
A 58-year-old female post-NSTEMI on carvedilol undergoes a symptom-limited Bruce protocol exercise test. At a heart rate of 124 bpm 124\text{ bpm} 124 bpm , she develops 1.5 mm 1.5\text{ mm} 1.5 mm of horizontal ST depression in leads V 5 – V 6 V_5\text{--}V_6 V 5 – V 6 accompanied by 2 / 4 2/4 2/4 substernal chest discomfort.
- Ischemic Threshold Heart Rate : 124 bpm 124\text{ bpm} 124 bpm
- Calculated Karvonen 50%–70% Zone : 108 to 126 bpm 108\text{ to } 126\text{ bpm} 108 to 126 bpm
- Ischemic Safety Cap : 124 − 10 = 114 bpm 124 - 10 = 114\text{ bpm} 124 − 10 = 114 bpm
Adjusted Clinical Exercise Prescription : Target heart rate is strictly restricted to 108 to 114 bpm 108\text{ to } 114\text{ bpm} 108 to 114 bpm (Borg RPE 11–13). Setting the workload to elicit heart rates ≥ 115 bpm \ge 115\text{ bpm} ≥ 115 bpm is clinically contraindicated.